Clinical Trial

An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

Name: An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis — clinical trial record (NCT07029555)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of the study is to determine the safety, tolerability, and pharmacokinetics of PIT565, in participants with rheumatoid arthritis (RA).

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-01

Trial Details

NCT Number	NCT07029555
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Rheumatoid Arthritis
Enrollment	57 participants
Start Date	2025-06-12
Primary Completion	2028-05-15 (estimated)
Study Completion	2028-05-16 (estimated)
Updated on ClinicalTrials.gov	2026-06-30